ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7G18122
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
BUY CHAPTERS

Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2025

Code: QYRE-Auto-7G18122
Report
May 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck KGaA
Organon
Gedeon Richter
Ferring
Changchun High Tech
Theramex

Recombinant Human Follicle Stimulating Hormone Injection Market Size

The global market for Recombinant Human Follicle Stimulating Hormone Injection was valued at US$ 1314 million in the year 2024 and is projected to reach a revised size of US$ 1881 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Recombinant Human Follicle Stimulating Hormone Injection Market

Recombinant Human Follicle Stimulating Hormone Injection Market

Recombinant follicle stimulating hormone is used in the treatment of female infertility and male hypogonadism. It is used in women who have a problem in ovulation or are undergoing fertility treatment like in-vitro fertilization. In men, it helps in the production of sperm cells.
Infertility affects many people at some point in their lives, according to a new report from the World Health Organization (WHO) released in 2023. About 17.5% of adults (about one in six people worldwide) experience infertility, highlighting the urgent need to expand access to affordable, high-quality reproductive health care for those who need it. Recombinant human follicle stimulating hormone is used in the treatment of female infertility and male hypogonadism. The safety and effectiveness of recombinant human follicle stimulating hormone have been verified in a large number of clinical applications. In the future, as biosimilar technology continues to mature and costs decrease, generic drugs will gradually break the market monopoly of original drugs and improve the accessibility of treatment. Generic drug companies will further enhance their market competitiveness by optimizing production processes, improving product quality and developing long-acting preparations.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Follicle Stimulating Hormone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Follicle Stimulating Hormone Injection.
The Recombinant Human Follicle Stimulating Hormone Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Follicle Stimulating Hormone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Follicle Stimulating Hormone Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Human Follicle Stimulating Hormone Injection Market Report

Report Metric Details
Report Name Recombinant Human Follicle Stimulating Hormone Injection Market
Accounted market size in year US$ 1314 million
Forecasted market size in 2031 US$ 1881 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 75IU
  • 150IU
  • 300IU
  • Others
Segment by Application
  • Women
  • Men
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Organon, Gedeon Richter, Ferring, Changchun High-Tech, Theramex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Human Follicle Stimulating Hormone Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Follicle Stimulating Hormone Injection Market growing?

Ans: The Recombinant Human Follicle Stimulating Hormone Injection Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Recombinant Human Follicle Stimulating Hormone Injection Market size in 2031?

Ans: The Recombinant Human Follicle Stimulating Hormone Injection Market size in 2031 will be US$ 1881 million.

Who are the main players in the Recombinant Human Follicle Stimulating Hormone Injection Market report?

Ans: The main players in the Recombinant Human Follicle Stimulating Hormone Injection Market are Merck KGaA, Organon, Gedeon Richter, Ferring, Changchun High-Tech, Theramex

What are the Application segmentation covered in the Recombinant Human Follicle Stimulating Hormone Injection Market report?

Ans: The Applications covered in the Recombinant Human Follicle Stimulating Hormone Injection Market report are Women, Men

What are the Type segmentation covered in the Recombinant Human Follicle Stimulating Hormone Injection Market report?

Ans: The Types covered in the Recombinant Human Follicle Stimulating Hormone Injection Market report are 75IU, 150IU, 300IU, Others

Recommended Reports

Recombinant Hormones

Infertility Treatments

Growth Hormone Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 75IU
1.2.3 150IU
1.2.4 300IU
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Perspective (2020-2031)
2.2 Global Recombinant Human Follicle Stimulating Hormone Injection Growth Trends by Region
2.2.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Human Follicle Stimulating Hormone Injection Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Human Follicle Stimulating Hormone Injection Market Dynamics
2.3.1 Recombinant Human Follicle Stimulating Hormone Injection Industry Trends
2.3.2 Recombinant Human Follicle Stimulating Hormone Injection Market Drivers
2.3.3 Recombinant Human Follicle Stimulating Hormone Injection Market Challenges
2.3.4 Recombinant Human Follicle Stimulating Hormone Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human Follicle Stimulating Hormone Injection Players by Revenue
3.1.1 Global Top Recombinant Human Follicle Stimulating Hormone Injection Players by Revenue (2020-2025)
3.1.2 Global Recombinant Human Follicle Stimulating Hormone Injection Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Human Follicle Stimulating Hormone Injection Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human Follicle Stimulating Hormone Injection Revenue
3.4 Global Recombinant Human Follicle Stimulating Hormone Injection Market Concentration Ratio
3.4.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Follicle Stimulating Hormone Injection Revenue in 2024
3.5 Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection Head office and Area Served
3.6 Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection, Product and Application
3.7 Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human Follicle Stimulating Hormone Injection Breakdown Data by Type
4.1 Global Recombinant Human Follicle Stimulating Hormone Injection Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Type (2026-2031)
5 Recombinant Human Follicle Stimulating Hormone Injection Breakdown Data by Application
5.1 Global Recombinant Human Follicle Stimulating Hormone Injection Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size (2020-2031)
6.2 North America Recombinant Human Follicle Stimulating Hormone Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025)
6.4 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size (2020-2031)
7.2 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025)
7.4 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size (2020-2031)
9.2 Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025)
9.4 Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.1.4 Merck KGaA Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Organon
11.2.1 Organon Company Details
11.2.2 Organon Business Overview
11.2.3 Organon Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.2.4 Organon Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.2.5 Organon Recent Development
11.3 Gedeon Richter
11.3.1 Gedeon Richter Company Details
11.3.2 Gedeon Richter Business Overview
11.3.3 Gedeon Richter Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.3.4 Gedeon Richter Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.3.5 Gedeon Richter Recent Development
11.4 Ferring
11.4.1 Ferring Company Details
11.4.2 Ferring Business Overview
11.4.3 Ferring Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.4.4 Ferring Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.4.5 Ferring Recent Development
11.5 Changchun High-Tech
11.5.1 Changchun High-Tech Company Details
11.5.2 Changchun High-Tech Business Overview
11.5.3 Changchun High-Tech Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.5.4 Changchun High-Tech Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.5.5 Changchun High-Tech Recent Development
11.6 Theramex
11.6.1 Theramex Company Details
11.6.2 Theramex Business Overview
11.6.3 Theramex Recombinant Human Follicle Stimulating Hormone Injection Introduction
11.6.4 Theramex Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
11.6.5 Theramex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck KGaA
Organon
Gedeon Richter
Ferring
Changchun High Tech
Theramex
List of Tables
 Table 1. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 75IU
 Table 3. Key Players of 150IU
 Table 4. Key Players of 300IU
 Table 5. Key Players of Others
 Table 6. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Region (2020-2025)
 Table 10. Global Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Region (2026-2031)
 Table 12. Recombinant Human Follicle Stimulating Hormone Injection Market Trends
 Table 13. Recombinant Human Follicle Stimulating Hormone Injection Market Drivers
 Table 14. Recombinant Human Follicle Stimulating Hormone Injection Market Challenges
 Table 15. Recombinant Human Follicle Stimulating Hormone Injection Market Restraints
 Table 16. Global Recombinant Human Follicle Stimulating Hormone Injection Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Players (2020-2025)
 Table 18. Global Top Recombinant Human Follicle Stimulating Hormone Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle Stimulating Hormone Injection as of 2024)
 Table 19. Ranking of Global Top Recombinant Human Follicle Stimulating Hormone Injection Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Recombinant Human Follicle Stimulating Hormone Injection Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection, Headquarters and Area Served
 Table 22. Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection, Product and Application
 Table 23. Global Key Players of Recombinant Human Follicle Stimulating Hormone Injection, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Recombinant Human Follicle Stimulating Hormone Injection Revenue Market Share by Type (2020-2025)
 Table 27. Global Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Recombinant Human Follicle Stimulating Hormone Injection Revenue Market Share by Type (2026-2031)
 Table 29. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Recombinant Human Follicle Stimulating Hormone Injection Revenue Market Share by Application (2020-2025)
 Table 31. Global Recombinant Human Follicle Stimulating Hormone Injection Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Recombinant Human Follicle Stimulating Hormone Injection Revenue Market Share by Application (2026-2031)
 Table 33. North America Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Merck KGaA Company Details
 Table 49. Merck KGaA Business Overview
 Table 50. Merck KGaA Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 51. Merck KGaA Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 52. Merck KGaA Recent Development
 Table 53. Organon Company Details
 Table 54. Organon Business Overview
 Table 55. Organon Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 56. Organon Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 57. Organon Recent Development
 Table 58. Gedeon Richter Company Details
 Table 59. Gedeon Richter Business Overview
 Table 60. Gedeon Richter Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 61. Gedeon Richter Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 62. Gedeon Richter Recent Development
 Table 63. Ferring Company Details
 Table 64. Ferring Business Overview
 Table 65. Ferring Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 66. Ferring Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 67. Ferring Recent Development
 Table 68. Changchun High-Tech Company Details
 Table 69. Changchun High-Tech Business Overview
 Table 70. Changchun High-Tech Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 71. Changchun High-Tech Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 72. Changchun High-Tech Recent Development
 Table 73. Theramex Company Details
 Table 74. Theramex Business Overview
 Table 75. Theramex Recombinant Human Follicle Stimulating Hormone Injection Product
 Table 76. Theramex Revenue in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025) & (US$ Million)
 Table 77. Theramex Recent Development
 Table 78. Research Programs/Design for This Report
 Table 79. Key Data Information from Secondary Sources
 Table 80. Key Data Information from Primary Sources
 Table 81. Authors List of This Report


List of Figures
 Figure 1. Recombinant Human Follicle Stimulating Hormone Injection Picture
 Figure 2. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Type: 2024 VS 2031
 Figure 4. 75IU Features
 Figure 5. 150IU Features
 Figure 6. 300IU Features
 Figure 7. Others Features
 Figure 8. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Application: 2024 VS 2031
 Figure 10. Women Case Studies
 Figure 11. Men Case Studies
 Figure 12. Recombinant Human Follicle Stimulating Hormone Injection Report Years Considered
 Figure 13. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Recombinant Human Follicle Stimulating Hormone Injection Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Region: 2024 VS 2031
 Figure 16. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Players in 2024
 Figure 17. Global Recombinant Human Follicle Stimulating Hormone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Recombinant Human Follicle Stimulating Hormone Injection Revenue in 2024
 Figure 19. North America Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Recombinant Human Follicle Stimulating Hormone Injection Market Share by Country (2020-2031)
 Figure 21. United States Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant Human Follicle Stimulating Hormone Injection Market Share by Country (2020-2031)
 Figure 25. Germany Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Share by Region (2020-2031)
 Figure 33. China Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Recombinant Human Follicle Stimulating Hormone Injection Market Share by Country (2020-2031)
 Figure 41. Mexico Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Share by Country (2020-2031)
 Figure 45. Turkey Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Recombinant Human Follicle Stimulating Hormone Injection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Merck KGaA Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 49. Organon Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 50. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 51. Ferring Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 52. Changchun High-Tech Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 53. Theramex Revenue Growth Rate in Recombinant Human Follicle Stimulating Hormone Injection Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Recombinant Human Growth Hormone Injections Market Research Report 2024
Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant FSH Injections Market Research Report 2024
Human Growth Hormone for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chorionic Gonadotropin for Injection Market Research Report 2025
Global Prefilled Human Growth Hormone Injection Market Research Report 2024
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Recombinant Human Follicle stimulating Hormone Market
Recombinant Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Interleukin 2 Injection Market Research Report 2024
Global Human Chorionic Gonadotrophin HCG Market Research Report 2025
Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024
Global Long acting Hormone Injection Market Research Report 2024
Global Human Recombinant Growth Factors Market Research Report 2025
Global Recombinant Human Serum Albumin Injection Market Research Report 2024
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Posterior Pituitary Injection Market Research Report 2024
Global Veterinary Follicle Stimulating Hormones FSH Market Research Report 2024
Global FSH Test Kit Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions